Comment on: "Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation"
- PMID: 28324438
- DOI: 10.1007/s40273-017-0493-5
Comment on: "Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation"
Comment in
-
Authors' Reply to Gandjour: "Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation".Pharmacoeconomics. 2017 May;35(5):605-606. doi: 10.1007/s40273-017-0498-0. Pharmacoeconomics. 2017. PMID: 28324439 No abstract available.
Comment on
-
Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation.Pharmacoeconomics. 2016 Mar;34(3):285-301. doi: 10.1007/s40273-015-0340-5. Pharmacoeconomics. 2016. PMID: 26547306 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical